NEWS - Jun 9, 2020 Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Read more
NEWS - May 29, 2020 Relmada Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference Read more
NEWS - May 27, 2020 Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder Read more
NEWS - May 26, 2020 Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations Read more
NEWS - Apr 28, 2020 Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs Read more
NEWS - Mar 31, 2020 Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety Read more
NEWS - Mar 24, 2020 Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development Read more
NEWS - Mar 9, 2020 Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development Read more
NEWS - Feb 25, 2020 Relmada Therapeutics to Present at 9th Annual SVB Leerink Global Healthcare Conference Read more
NEWS - Jan 10, 2020 Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer Read more
